Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced the launch of their pre-clinical study on human adipose derived mesenchymal progenitor cell therapy for asthma.
http://ift.tt/1gvcUur
http://ift.tt/1gvcUur
No comments:
Post a Comment